Form 4: CRL Executive Gifts Shares, Updates Holdings

Sentiment:

Insider Transaction Report


Charles River Laboratories' Corporate Executive VP & COO, Birgit Girshick, reported gifting 328 shares of common stock and reclassifying other holdings.

Summary

  • Birgit Girshick, Corporate Executive VP & COO of Charles River Laboratories International, Inc. (CRL), reported a transaction on a Form 4 filing.
  • On March 4, 2026, Girshick disposed of 328 shares of common stock via a gift (Transaction Code G) at a price of $0 per share.
  • Following this transaction, Girshick's beneficial ownership includes 40,417 shares held indirectly through a Revocable Trust and 31,638 shares held directly, totaling 72,055 shares.
  • The filing also clarifies that shares previously reported as directly held are now correctly reported as indirectly held within the Revocable Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. A gift of shares is a personal financial decision and does not typically signal a change in the company's operational or financial health.

Positives

  • The transaction involves a gift, which is a personal financial decision and not typically indicative of negative sentiment towards the company's future performance.

Negatives

  • A disposition of shares, even as a gift, reduces the insider's direct equity stake in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, such as gifts, are routine disclosures under SEC regulations. While a disposition reduces an insider's direct stake, gifts are often for personal estate planning and do not necessarily reflect a change in the executive's outlook on the company's operational performance or future prospects, unlike open market sales.

Stakeholder Impact

  • Shareholders: A minor reduction in insider ownership, but generally not a significant event for overall shareholder value.

Key Dates

DateDescription
03/04/2026Date of transaction where 328 shares of common stock were disposed of by gift.
03/05/2026Date the Form 4 was signed by Birgit Girshick.

Recommendation

hold

The filing reports a routine insider transaction involving a gift of a small number of shares. This type of personal financial decision by an executive typically has no material impact on the company's fundamentals or future prospects, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

Charles River Laboratories, CRL, Birgit Girshick, Insider Transaction, Form 4, Stock Gift, Beneficial Ownership, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.